Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s disease
- First Online:
- Cite this article as:
- Youm, J.W., Jeon, J.H., Kim, H. et al. Biotechnol Lett (2008) 30: 1839. doi:10.1007/s10529-008-9759-5
- 1.1k Downloads
Human β-amyloid (Aβ) is believed to be one of the main components of Alzheimer’s disease, so reduction of Aβ is considered a key therapeutic target. Using Agrobacterium-mediated nuclear transformation, we generated transgenic tomatoes for Aβ with tandem repeats. Integration of the human Aβ gene into the tomato genome and its transcription were detected by PCR and Northern blot, respectively. Expression of the Aβ protein was confirmed by western blot and ELISA, and then the transgenic tomato line expressing the highest protein level was selected for vaccination. Mice immunized orally with total soluble extracts from the transgenic tomato plants elicited an immune response after receiving a booster. The results indicate that tomato plants may provide a useful system for the production of human Aβ antigen.
KeywordsAlzheimer’s diseaseEdible vaccineImmunogenicityTomato-derived beta amyloid
Alzheimer’s disease (AD) is a neurodegenerative disease and the most common cause of dementia which progresses over a prolonged period. According to what is currently known about AD, it is believed to be caused by the accumulation of beta-amyloid (Aβ), a toxic protein, in the brain. This ultimately results in neuronal death (Taylor et al. 2002; Hardy and Salkoe 2002). Therefore, an effective strategy for the prevention and treatment of the underlying causes of AD would be to develop an agent that inhibits the degeneration of the nervous system via the suppression of Aβ generation, thus circumventing its associated toxicity. Reducing the accumulation of Aβ may prevent or delay the onset of Alzheimer’s disease. In a recent study, a variety of vaccination advances were made using the Aβ peptide. Schenk et al. (1999) and Morgan et al. (2000) immunized transgenic mice with purified Aβ and raised an antibody against the 42-amino acid form of Aβ.
It is difficult to produce Aβ through E. coli or yeast expression systems because of the toxicity of the protein. For this reason, the possibility of Aβ expression in plant cells was investigated. Transgenic plants are considered to be an alternative system for the useful production of recombinant proteins, such as antibodies, antigens, and therapeutics. During the last 15 years, various antigens have been successfully produced in plants and orally delivered to animals resulting in induced immune responses (Mason et al. 1996; Tacket et al. 1998; Richter et al. 2000). The first step was examining the effect of plant-derived Aβ on the induction of an immune response in transgenic mice (Youm et al. 2005). Immunization with potato-derived 5Aβ42 can reduce the Aβ burden as well as many of the pathological features found in a transgenic AD mouse model.
Various crops have been used to develop plant-derived antigens. Each plant has advantages and disadvantages (Sala et al. 2003). Plants such as tobacco and alfalfa often produce proteins in their green leaf tissues, but these tend to contain high concentrations of phenolic and other potentially toxic compounds. Seeds are likely to have fewer phenolic compounds and a less complex mixture of proteins and lipids than green leaves, which might be an advantage during purification. In the case of the tomato plant, tomatoes can be eaten without heat treatment, which may destroy the immunogenicity of the antigen. Furthermore, transgenic tomatoes are exhibiting considerable potential for the economic production of proteins, with a few already being marketed (Horn et al. 2004).
In the current study, we carried out the cloning and expression of three to five tandem repeats forms of Aβ in tomato plants in an attempt to develop a plant-derived AD vaccine. The ability of tomato-derived Aβ antigen to evoke antibody responses in mice was analyzed. Immunized mice produced serum antibodies against the Aβ antigen. We confirmed that it is feasible to produce the Aβ protein in transgenic tomatoes and to serve as a novel delivery system for the oral immunization of BALB/c mice.
Materials and methods
Agrobacterium-mediated transformation of the tomato was carried out with the Housechallenge cultivar as described by Frary and Hamilton (2001). Seeds were sterilized with 15% sodium hypochloride solution for 10 min and washed 2–3 times with sterile distilled water. Sterilized seeds were cultivated on MS tissue culture medium (Murashige and Skoog 1962) at 25°C with 16 h of light a day. Ten days later, fully expanded cotyledons were used for the plant transformation.
Tomato transformation and regeneration
PCR analysis and Southern hybridization
The presence of inserted DNA in the tomato genome was cross-checked by PCR analysis for both the neomycin phophotransferase II (npt II) and Aβ gene. PCR analysis for the npt II gene was performed as described previously (Kim et al. 2003). Total genomic DNA from non-transformed (NT) plants was used as a negative control and all putative kanamycin resistant plants were extracted as described by Doyle and Doyle (1987). A 20 μl PCR reaction mix contained 100 ng of each primer, premix solution (Bioneer Co., Korea), and 100 ng genomic DNA as template. Cycling conditions were 94°C for 45 min, 65°C for 30 min, and 72°C for 30 min for a total 25 cycles. The primer sequences used to amplify the Aβ gene were 5′-GGA TCC ATG GAT GCA GAA TCC CGA CAT GAC-3′ and 5′-GGA TCC TCA CGC TAT GAC AAC ACC GCC CAC-3′. The amplified DNA fragments were separated by electrophoresis on a 1.5% agarose gel and visualized by ethidium bromide staining.
Northern blot analysis
Total RNA from the leaves of NT plants and transformed plants was isolated using the RNAgents Total RNA isolation system (Promega, WI, USA) according to the manufacturer’s instructions. Thirty μg total RNA was denatured with formaldehyde and formamide, fractionated in a 1% agarose gel using MOPS buffer and then blotted to a positively charged nylon membrane. The membranes were hybridized with Dig-labeled Aβ-specific probe at 68°C overnight and detected using the Dig Detection kit (Roche Co., Germany).
Western and ELISA analysis to detect Aβ protein
Protein extraction and analysis of 3Aβ-expressing lines were performed as described in previous studies (Kim et al. 2003; Youm et al. 2005). Total soluble protein (TSP) was extracted from NT control and transgenic tomato plants by homogenizing in extraction buffer, and quantified by the Bradford method.
Western blot analysis was performed using anti-Aβ monoclonal antibody, 4G8 (1:5,000 dilution, Signet Lab., MA, USA). A chemiluminiscence kit (Amersham Bioscience, UK) was used to visualize the specific bands. The recombinant 3Aβ protein levels were determined via direct ELISA assays. The ELISA plate were coated with 100 μg TSP in 0.05 M carbonate/bicarbonate (pH 9.6) buffer and incubated with anti-Aβ monoclonal antibody (6E10, 1:1,000 dilution, Signet Lab.). The amount of Aβ proteins in TSP was estimated with Aβ42 peptide as a standard.
Vaccination of Balb/c mice with transformed plant extract
A group of 15 month old Balb/c mice was used in the immunization experiments. Ten mice from each group were fed extracts from transgenic tomato line pMBP3Aβ-6 or NT control plants plus 10 μg Cholera Toxin B subunit (CTB) (Sigma) once a week for 3 weeks. Prior to the oral immunizations, 0.2 ml sodium bicarbonate was applied by gastric gavage to each of the mice, in order to neutralize stomach acidity. Blood samples were collected just before the examination (day 0) and after primary immunization. Each mouse was given a booster at 4 weeks after the 3rd feeding with 15 μg of synthetic Aβ peptide emulsified in alum. Sera were collected from the mice 2 weeks after boosting, and all blood samples were analyzed by ELISA assays.
Direct ELISA for anti-Aβ antibody production
Flat-bottom ELISA plates were coated overnight at 4°C with Aβ 42 (0.1 μg/well of 0.05 M carbonate/bicarbonate buffer, pH 9.6) to measure the titers of anti-Aβ antibodies in the sera of immunized mice. Most of the procedures were the same as previously described (Youm et al. 2005). Briefly, the coated plates were incubated with serum samples, diluted 1:100 in blocking buffer, for 2 h at room temperature. The plates were then incubated with mouse IgG-conjugated horseradish peroxidase (secondary antibody), diluted 1:1,000 in blocking buffer, for 2 h at room temperature. To stop the reaction, 100 μl tetramethylbenzidine substrate (Pierce, IL, USA) and H2O2 were added. After incubation, the reaction was measured at 450 nm with an ELISA reader.
Generation of transgenic tomato plants
Three multimer forms of Aβ, trimer to pentamer, were successfully introduced into the pMBP1 vector. The immunogenicity of each multimer form of synthetic Aβ was determined by western blot with an anti-Aβ antibody. Four weeks after co-cultivation, shoots were developed from cotyledon-disc segments (Fig. 1c, left) and putative transformants selected through kanamycin resistance (Fig. 1c, middle). We obtained more than 20 individual plantlets and carried out further analysis of Aβ expression on selected transgenic plants. Non-transformed tomato plants regenerated from non-contaminated cotyledon discs were used as negative controls. The selected transformants exhibited similar growth with no phenotypic abnormalities compared to the NT plants (Fig. 1c, right).
Analysis of Aβ expression in tomato transformants
The transcription of 3Aβ, 4Aβ, and 5Aβ DNA in transgenic plants was determined by Northern analysis. Fig. 2b shows the results of an experiment where selected transformants harboring the pMBPn(3–5)Aβ constructs and a NT control were probed. An Aβ-specific RNA was found in six lines of transgenic 3Aβ, two lines of transgenic 4Aβ, and one line of transgenic 5Aβ, but at quite different levels.
Immunogenicity of tomato-derived 3Aβ
The expression levels were different between the various transform ants and can be different between organs of the same plant, which depends on the site the foreign DNA is inserted into the plant genome. Ma et al. (2003) reported that the expression of HEV in tomato fruits (61 ng/g fresh weight) is higher than in leaves, and is similar to that of Bag in transgenic tomatoes (Lou et al. 2007). The higher expression of target protein in edible tissue may be helpful for producing an oral vaccine. In this study, a high level of Aβ transcript was found in the transgenic 3Aβ lines, with a lower expression of the transgenic 4Aβ and 5Aβ lines than expected. It is not caused by the multimer form of Aβ, because we previously showed good expression of the 5-mer in the potato (Youm et al. 2005).
An advantage of using tomatoes as an oral vaccine vector is that the tomato is a freshly eaten fruit, meaning it is possible to acquire immunity at the same time as enjoying food. However, the accumulation of protein in the tomato itself is low as it contains only 0.7% protein in the fresh fruit and the expression levels of foreign protein are much lower. In the context of this study, tomato-derived 3Aβ is expressed at lower levels than potato-derived 5Aβ using the same vector system. This will make it difficult when administering the plant-derived vaccine. To resolve this problem, the use of stronger promoters, plant-derived leader sequences and signal peptides, plant-optimized synthetic genes, and targeting the protein for retention in the appropriate tissue (Stoical et al. 2003; Tackaberry et al. 2003; Lauterslager et al. 2001) have been investigated. In our previous study, 5Aβ protein was increased up to 0.1% of TSP by introducing a strong promoter, signal peptide, and retention signal into the expression vector (Youm et al. 2005). All of these studies provided successful experiences in improving the expression level of antigen in transgenic tomatoes. In the present study, we introduced cDNA encoding 3Aβ into the pMBP1 expression vector driven by the CaMV 35S promoter without any enhancing factor, though there were many reconstruction possibilities to achieve high expression. We are currently engaged in research for increasing the expression level of foreign proteins using a tissue-specific promoter or signal peptide for subcellular localization.
In several reports, an immediate and strong secondary antibody response was observed in animals receiving a boost of commercial vaccine (Richter et al. 2000; Kong et al. 2001). Memory immune cells had apparently been established as a result of oral immunization. Our results in this study showed that mice fed extract from transgenic tomato line 3Aβ-6 exhibited a significant increase in serum against Aβ after boosting compared to the primary antibody response. Although we did not reveal a reduction of existing plaques in the brain of mice challenged with tomato-derived 3Aβ, we expect a similar result to what was found in our previous study (Youm et al. 2005) induced serum antibodies affect amyloid plaques in the brain resulting in a reduction in amyloid number or amyloid burden in the brain (Schenk et al. 1999; Morgan et al. 2000; Youm et al. 2005).
One promising approach to the prevention and treatment of AD is based upon stimulating the immune system to reduce Aβ in the brain. There is still much optimism in regard to the eventual development of a vaccine strategy using Aβ (Gelinas et al. 2004). This study constitutes another example of active immunization, and also represents a unique approach in which transgenic plants expressing Aβ protein are used to produce the vaccine.
This research was supported by a grant from the Plant Diversity Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education and Science of the Korean government.